Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.verified

BLCM

Price:

$0.07475

Market Cap:

$778.33K

Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-c...[Read more]

Industry

Biotechnology

IPO Date

2014-12-18

Stock Exchange

NASDAQ

Ticker

BLCM

The Enterprise Value as of June 2026 (TTM) for Bellicum Pharmaceuticals, Inc. (BLCM) is -21058674.00

According to Bellicum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -21058674.00. This represents a change of -2561.44% compared to the average of 855.54K of the last 4 quarters.

Bellicum Pharmaceuticals, Inc. (BLCM) Historical Enterprise Value (quarterly & annually)

How has BLCM Enterprise Value performed in the past?

The mean historical Enterprise Value of Bellicum Pharmaceuticals, Inc. over the last ten years is 174.80M. The current -21058674.00 Enterprise Value has changed -1304.76% with respect to the historical average. Over the past ten years (40 quarters), BLCM's Enterprise Value was at its highest in in the September 2014 quarter at 530.45M. The Enterprise Value was at its lowest in in the December 2021 quarter at -22744827.96.

Quarterly (TTM)
Annual

Average

174.80M

Median

167.03M

Minimum

-29014601.94

Maximum

463.94M

Bellicum Pharmaceuticals, Inc. (BLCM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bellicum Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.36%

Maximum Annual Enterprise Value = 463.94M

Minimum Annual Increase = -288.08%

Minimum Annual Enterprise Value = -29014601.94

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022359.34K-101.24%
2021-29014601.94107.36%
2020-13992638.73-288.08%
20197.44M-93.22%
2018109.74M-58.27%
2017262.99M-21.66%
2016335.72M-27.64%
2015463.94M20.05%
2014386.46M72.28%
2013224.32M-3.93%

Bellicum Pharmaceuticals, Inc. (BLCM) Average Enterprise Value

How has BLCM Enterprise Value performed in the past?

The current Enterprise Value of Bellicum Pharmaceuticals, Inc. (BLCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-14215967.61

5-year avg

14.91M

10-year avg

174.80M

Bellicum Pharmaceuticals, Inc. (BLCM) Enterprise Value vs. Peers

How is BLCM’s Enterprise Value compared to its peers?

Bellicum Pharmaceuticals, Inc.’s Enterprise Value is less than Infinity Pharmaceuticals, Inc. (9.83M), less than PAVmed Inc. (13.24M), less than InVivo Therapeutics Holdings Corporation (-14406082.00), less than Impel Pharmaceuticals Inc. (-8512000.00), less than Anew Medical, Inc. (16.87M), less than Peak Bio, Inc. (519.80K), less than Acorda Therapeutics, Inc. (161.36M), less than BiomX Inc. (-313529.00), less than 9 Meters Biopharma, Inc. (0), less than BIOLASE, Inc. (12.08M),

Build a custom stock screener for Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellicum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellicum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bellicum Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 3-year average Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 5-year average Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM)?

How does the current Enterprise Value for Bellicum Pharmaceuticals, Inc. (BLCM) compare to its historical average?